ENTITY
Shanghai Bio-heart Biological Technology

Shanghai Bio-heart Biological Technology (2185 HK)

20
Analysis
Industrials • China
Shanghai Bio-heart Biological Technology is an interventional cardiovascular device company that develops innovative therapies for unmet medical needs in the treatment of coronary artery disease and hypertension. Its key products include the Bioheart bioresorbable scaffolds (BRS) system, the Iberis 2nd renal denervation (RDN) product candidate, and drug-coated balloons (DCB). The company was founded in 2014 and is headquartered in Shanghai, People's Republic of China.
more
Exchange Announcement • 09 Oct 2026 20:19

List Of Directors And Their Roles And Functions

Exchange Announcement • 09 Oct 2026 20:18

(1) Poll Results Of The 2026 First Extraordinary General Meeting Held On October 9, 2026; (2) Resignation Of Independent Non-Executive Director; (3) Appointment Of Independent Non-Executive Director; And (4) Change Of Composition Of Board Committees

Exchange Announcement • 29 Sep 2026 16:39

2026 Interim Report

Exchange Announcement • 23 Sep 2026 16:50

Proxy Form For Use At The 2026 First Extraordinary General Meeting To Be Held On October 9, 2026

Exchange Announcement • 23 Sep 2026 16:48

(1) Proposed Appointment Of Independent Non-Executive Director; And (2) Notice Of 2026 First Extraordinary General Meeting

x